Percutaneous coronary intervention plus optimal medical therapy was not more effective than medical therapy alone in stable CAD: COMMENTARY

Pitt, Bertram
July 2007
ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p12
Academic Journal
The author reflects on a study, conducted by W.E. Boden and colleagues, which compares the effectiveness of percutaneous coronary intervention (PCI) plus optimal medical therapy (OMT) and OMT alone for preventing cardiovascular events in patients with stable coronary artery disease (CAD). He views that the use of drug-eluting stents (DLS) in the study was suboptimal; however, no evidence exists that DLS decrease the incidence of myocardial infarction (MI) compared with bare-metal stents.


Related Articles

  • Bare-metal and drug-eluting stents yield similar cardiac event risks, according to pooled analysis.  // Formulary;Aug2007, Vol. 42 Issue 8, p493 

    The article focuses on the cardiac event risk generated by bare-metal and drug-eluting stents among patients with De Novo Native Coronary Artery Lesions (RAVEL). Trials in this study contradicted the results of the trials demonstrating that risks for death and myocardial infarction (MI) are...

  • Stenting of the Unprotected Left Main Coronary Artery in a Nonagenarian Presenting with Recurrent Non-ST Elevation Myocardial Infarction. Raizada, Amol; Petrasko, Marian; Stys, Tomasz P.; Stys, Adam T. // South Dakota Medicine;Jul2014, Vol. 67 Issue 7, p265 

    Coronary artery disease (CAD) involving the left main (LM) artery has traditionally been considered an indication for coronary artery bypass surgery (CABG). With recent advances in the field of percutaneous coronary interventions (PCI), angioplasty and stenting of the unprotected' LM has been...

  • Single Coronary Artery and Trombus Aspiration: A Case Report. ERTEM, Ahmet Göktuğ; HAN EFE, Tolga; AYTÜRK, Mehmet; YETER, Ekrem // Ortadogu Medical Journal / Ortadogu Tip Dergisi;2013, Vol. 5 Issue 3, p178 

    We report a case of isolated single coronary artery. A 65 year-old man was presented with chest pain, who was diagnosed as inferior myocardial infarction. During coronary angiography, we revealed single coronary artery, originating from right sinus valsalva, and stenosis on right coronary...

  • Very late presentation ventricular septal defect following myocardial infarction. Yu, Emma P. K.; O'Sullivan, Michael // Postgraduate Medical Journal;May2011, Vol. 87 Issue 1027, p386 

    The article deals with very late presentation ventricular septal defect following myocardial infarction (MI). It cites the case of a 64-year-old man, who was admitted to hospital with shortness of breath and abdominal swelling. The background history of the patient included an inferior...

  • Sirolimus-Eluting vs Uncoated Stents for Prevention of Restenosis in Small Coronary Arteries: A Randomized Trial. Ardissino, Diego; Cavallini, Claudio; Bramucci, Ezio; Indolfi, Ciro; Marzocchi, Antonio; Manari, Antonio; Angeloni, Giulia; Carosio, Giuseppe; Bonizzoni, Erminio; Colusso, Stefania; Repetto, Monica; Merlini, Piera Angelica // JAMA: Journal of the American Medical Association;12/8/2004, Vol. 292 Issue 22, p2727 

    Context Percutaneous coronary revascularization of small vessels is associated with a high restenosis rate. Sirolimus-eluting stents reduce restenosis in simple and previously untreated lesions of large coronary arteries, but their outcomes in small vessels have not been adequately investigated....

  • Drug-eluting stents: do the risks really outweigh the benefits? Austin, David; Pell, Jill P.; Oldroyd, Keith G. // Heart;Feb2008, Vol. 94 Issue 2, p127 

    The article focuses on the benefit and risk of using drug-eluting stents (DES) in an individual patient undergoing percutaneous coronary intervention (PCI). It is noted that the DES have a clinical efficacy in reducing restenosis of up to 10%. There are several randomized clinical trials (RCT)...

  • One year comparison of costs of coronary surgery' versus percutaneous coronary intervention in the stent or surgery trial. Weintraub, W. S.; Mahoney, E. M.; Zhang, Z.; Chu, H.; Hutton, J.; Buxton, M.; Booth, J.; Nugara, F.; Stables, R. H.; Dooley, P.; Collison, J.; Stutsville, M.; Delahunty, N.; Wright, A.; Flather, M. D.; De Cock, E. // Heart;Jul2004, Vol. 90 Issue 7, p782 

    Objectives: To compare initial and one year costs of coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) in the stent or surgery trial. Design: Prospective, unblinded, randomised trial. Setting: Multicentre study. Patients: 988 patients with multivessel...

  • A Prospective Trial of Ayurveda for Coronary Heart Disease: A Pilot Study. DuBroff, Robert; Lad, Vasant; Murray-Krezan, Cristina // Alternative Therapies in Health & Medicine;Sep/Oct2015, Vol. 21 Issue 5, p52 

    Context: Coronary heart disease is the leading cause of death worldwide, and its incidence is rapidly accelerating in developing nations. Patients often search for therapies that are alternatives to traditional treatments, such as heart medicines, coronary bypass surgery, or...

  • KASNA TROMBOZA STENTA. PETROVIĆ, Milovan; BIKICKI, Miroslav; PANIĆ, Gordana; ČANJI, Tibor; SRDANOVIČ, Ilija; IVANOVIČ, Vladimir // Medicinski Pregled / Medical Review;2009, Vol. 62 Issue 1/2, p79 

    Introduction Late stent thrombosis is a serious complication after stent implantation and it can lead to the devolpment of acute myocardial infarction or death. A case report A 43-year-old patient was admitted to our clinic to coronary care unit. He was diagnosed with acute ST elevation...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics